THE WOODLANDS, Texas, March 22, 2017 -- Nexeo Solutions, Inc. (NASDAQ:NXEO) (“Company”), a leader in chemicals and plastics distribution, announced today, through its wholly owned subsidiaries, has entered into an Amended Credit Agreement (the “Amendment”) to its Term Loan Credit Facility.
The Amendment reflects a 50 basis points reduction in the interest rate to LIBOR plus 3.75% from LIBOR plus 4.25% and removal of the 1% LIBOR floor. The Amendment also provides a prepayment premium equal to 1% of the amount of the term loan applicable to certain repricing transactions occurring on or prior to six months from the effective date of the Amendment. The Amendment will result in an estimated $3.3 million reduction to the Company’s annual cash interest expense for each of the next six years, while all other terms remain unchanged. There were no changes to the total or secured leverage ratios as a result of the Amendment.
About Nexeo Solutions, Inc.
Nexeo Solutions is a leading global chemicals and plastics distributor, representing products from world-class producers to a diverse customer base. From product specification to sustainable solutions, the Company goes beyond traditional logistics to provide value-added services across many industries, including chemicals manufacturing, oil and gas, coatings, personal care, healthcare, automotive and 3D printing. The Company leverages a centralized technology platform to identify efficiencies and create solutions to unlock value for suppliers and customers. Learn more at www.nexeosolutions.com.
Forward-Looking Statements
This press release contains statements related to the Company’s future plans and expectations and, as such, includes “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements are those statements that are based upon management’s current plans and expectations as opposed to historical and current facts. Although the forward-looking statements contained in this press release reflect management’s current assumptions based upon information currently available to management and based upon that which management believes to be reasonable assumptions, the Company cannot be certain that actual results will be consistent with these forward-looking statements. The Company’s future results will depend upon various risks and uncertainties, as well as the risks and uncertainties discussed in the Company’s SEC filings, including the sections entitled “Risk Factors” in such SEC filings. The Company does not intend to provide all information enclosed in this press release on an ongoing basis.
For Further Information Please Contact Investor Relations, Nexeo Solutions Tel: +1.281.297.0856, [email protected] Media Relations, Nexeo Solutions Tel: +1.281.297.0851, [email protected]


Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 



